Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-04-24

Clinical Trial Update: Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder [NA]

View source ↗

Summary

A completed clinical trial evaluating galantamine-CR for cognitive dysfunction in bipolar disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine-CR (galantamine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Bipolar Disorder | NA | Status: COMPLETED